Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate for Adenomyosis
NCT03325868Phase 4Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ulipristal in adenomyosis, sponsored by Vanderbilt University Medical Center. Planned start Feb 2018; status: withdrawn.
02
Drugs
ulipristal
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT03325868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325868.